Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Ȩ > ±Û·Î¹ú ÆÄÆ®³Ê > P > PharmaVentures Ltd
Áö¿ª
Ä«Å×°í¸®·Î ã±â
ÆÄ¸Ó½´Æ¼ÄÃ

PharmaVentures Ltd

PharmaVentures Ltd ¿¡¼­ ¹ßÇàÇÑ ÀÚ·á ¸®½ºÆ®ÀÔ´Ï´Ù.

»ó¼¼ ºÐ·ù
Á¦¸ñ °Ë»ö
1 - 8 ¸®ºä (Àüü£º 8 °Ç) Á¤·Ä Ç¥½Ã °Ç¼ö
The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
»ùÇÃ
»óǰÄÚµå :230265
Á¦¾à ¾÷°èÀÇ ·Î¿­Æ¼À²(Royalty Rate)¿¡ ´ëÇØ ºÐ¼®Çϰí, °¢Á¾ °è¾à ¹× ·Î¿­Æ¼ ±¸Á¶, À¯È¿ÇÑ ·Î¿­Æ¼ ºñ±³ ºÐ¼®, ·Î¿­Æ¼ »êÃâ, ¼øÇöÀç°¡Ä¡(NPV)¿Í ±â´ë ¼øÇöÀç°¡Ä¡(ENPV) »êÃâ, ´Ü°è ¹× ÀûÀÀÁõº° ·Î¿­Æ¼À², °ú°Å 5³â°£ ·Î¿­Æ¼À² º¯È­ µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 8,005
¹ßÇàÀÏ 2012³â 03¿ù
¸®¼­Ä¡»ç PharmaVentures Ltd
ÆäÀÌÁö¼ö  
Essential Deal Trends: Oncology 2011
»ùÇÃ
»óǰÄÚµå :221315
¾Ï(Oncology) ½ÃÀåÀÇ ÇÕº´, Àμö, ¶óÀ̼¾½Ì µîÀÇ Áß¿ä °Å·¡ µ¿ÇâÀ» Á¤¸®Çϰí, 2000³â ÀÌÈÄÀÇ ½ÇÀû°ú ÇâÈÄ ¿¹ÃøÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,395
¹ßÇàȽ¼ö 12 ȸ / ³â
¸®¼­Ä¡»ç PharmaVentures Ltd
ÆäÀÌÁö¼ö 60 Pages
Analysis of Deal Making in Vaccines
»ùÇÃ
»óǰÄÚµå :138235
¹é½Å ½ÃÀåÀÇ °Å·¡ µ¿Çâ¿¡ ´ëÇØ ºÐ¼®ÇßÀ¸¸ç, Ä¡·á ºÐ¾ßº°, Á¾·ùº°, °³¹ß ´Ü°èº°, Á¦Ç°º° µîÀÇ ºÎ¹®º° µ¿Çâ°ú Âü¿©±â¾÷ÀÇ °³¿ä, ÄÉÀ̽º½ºÅ͵𸦠Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,344
¹ßÇàÀÏ 2010³â 11¿ù
¸®¼­Ä¡»ç PharmaVentures Ltd
ÆäÀÌÁö¼ö  
Analysis of Deals in Neurodegenerative Diseases
»ùÇÃ
»óǰÄÚµå :127549
½Å°æ º¯¼º Áúȯ(¾ËÃ÷ÇÏÀ̸Ӻ´, ÆÄŲ½¼º´, ´Ù¹ß¼º °æÈ­Áõ, °£Áú, ÆíµÎÅë µî)ÀÇ °³¿ä¿Í ½ÃÀå ±Ô¸ð, ÇöÀç Ä¡·á¹ý°ú °³¹ß ÁßÀÎ Á¦Ç° µ¿Çâ, Á¾·ù¡¤°³¹ß ´Ü°è¡¤Á¦Ç°º° °Å·¡ µ¿Çâ µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,344
¹ßÇàÀÏ 2010³â 07¿ù
¸®¼­Ä¡»ç PharmaVentures Ltd
ÆäÀÌÁö¼ö  
Analysis of Oncology Deals: Trends in Deal Structures and Valuations
»ùÇÃ
»óǰÄÚµå :104712
¾Ï ½ÃÀå Âü°¡ ±â¾÷ÀÇ °³¿ä¿Í ÁÖ¸ñÇØ¾ß ÇÒ Áß¼Ò±â¾÷, ±ÝÀ¶À§±â°¡ µ¿ ½ÃÀå¿¡¼­ÀÇ ±â¾÷ °Å·¡¿¡ ¹ÌÄ£ ¿µÇâ, ½ÅÈï ½ÃÀåÀÇ µ¿Çâ, ÇâÈÄÀÇ °Å·¡¸¦ ÃËÁøÇϱâ À§ÇÑ »õ·Î¿î Å×Å©³î·¯Áö¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,395
¹ßÇàÀÏ 2009³â 12¿ù
¸®¼­Ä¡»ç PharmaVentures Ltd
ÆäÀÌÁö¼ö 100 PAGES
Trends in Pharmaceutical Deal Making, An analysis of valuations, deal structures and deal types
»ùÇÃ
»óǰÄÚµå :89954
Á¦¾à±â¾÷ÀÇ °è¾à µ¿Çâ¿¡ ´ëÇØ °è¾à À¯Çüº°·Î Á¶»ç ºÐ¼®Çϰí, °¢Á¾ °è¾àÀÇ ÇÕ¸®¼º, °¢Á¾ °è¾àÀÇ Æò°¡ ¹æ¹ý, °¢Á¾ °è¾àÀÇ ±Ô¸ð(Áö¿ª¡¤ÀÓ»ó ºÐ¾ßº°), ÁÖ¿ä±â¾÷ »ç·Ê¿¬±¸ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,450
¹ßÇàÀÏ 2009³â 06¿ù
¸®¼­Ä¡»ç PharmaVentures Ltd
ÆäÀÌÁö¼ö 97 Pages
Guide to Valuation of Pharmaceutical Licensing Deals
»ùÇÃ
»óǰÄÚµå :89963
´ë±Ô¸ð Á¦¾à ȸ»ç ¹× ¹ÙÀÌ¿À ±â¾÷, Çмú ±â°ü°úÀÇ ³×Æ®¿öÅ© ¾È¿¡¼­ ÇàÇØÁö´Â ¶óÀ̼¾½º °è¾àÀÇ ´Ù¾çÇÑ ¹®Á¦Á¡¿¡ ÃÊÁ¡À» ¸ÂÃß¾î Á¤È®ÇÑ °¡Ä¡ Æò°¡ ¹× °¡Ä¡ âÃâ ÇÁ·Î¼¼½º, ÇâÈÄÀÇ ¼Õ½Ç ÃÖ¼ÒÈ­¸¦ À§ÇÑ Àü·« µîÀ» Á¤¸®ÇØ µå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,450
¹ßÇàÀÏ 2009³â 03¿ù
¸®¼­Ä¡»ç PharmaVentures Ltd
ÆäÀÌÁö¼ö 98 Pages
»ùÇÃ
»óǰÄÚµå :89955
ÀǾàǰ ¾÷°èÀÇ ¾à¹° Àü´Þ(Drug Delivery)À» À§ÇÑ Àü·«°ú Ÿ»ç¿ÍÀÇ Á¦ÈÞ °è¾à, ´ë±Ô¸ð Á¦¾à ȸ»çÀÇ Á¦ÈÞ »ç·Ê ¹× Á¦ÈÞ °³¹ß ÇÁ·Î¼¼½º µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,993
¹ßÇàÀÏ 2009³â 01¿ù
¸®¼­Ä¡»ç PharmaVentures Ltd
ÆäÀÌÁö¼ö 142 Pages

»ó±â ÀÚ·á ÀÌ¿ÜÀÇ PharmaVentures Ltd ÀÚ·áµµ ÁÖ¹® °¡´ÉÇÏ´Ï ¹®ÀÇÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.